NasdaqGS - Nasdaq Real Time Price USD

Progyny, Inc. (PGNY)

26.95 +0.33 (+1.24%)
At close: May 31 at 4:00 PM EDT
28.00 +1.05 (+3.90%)
After hours: May 31 at 7:47 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. David J. Schlanger Executive Chairman 513.57k 46.8M 1959
Mr. Peter Anevski CEO & Director 1.09M 21.17M 1967
Mr. Michael Sturmer President 836.49k -- 1977
Mr. Mark S. Livingston Chief Financial Officer 749.56k 1.36M 1966
Ms. Allison Swartz Executive VP, General Counsel & Secretary 546.22k -- 1990
Mr. Steven Leist Chief Technology Officer -- -- --
Mr. James Hart Vice President of Investor Relations -- -- --
Ms. Risa Fisher Chief Marketing Officer -- -- --
Ms. Cassandra Pratt Chief Human Resources Officer -- -- --
Ms. Julie Stadlbauer Chief Business Development Officer -- -- --

Progyny, Inc.

1359 Broadway
New York, NY 10018
United States
212 888 3124 https://www.progyny.com
Sector: 
Healthcare
Full Time Employees: 
563

Description

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Corporate Governance

Progyny, Inc.’s ISS Governance QualityScore as of June 1, 2024 is 7. The pillar scores are Audit: 6; Board: 7; Shareholder Rights: 7; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 1, 2024 at 10:59 AM UTC - August 5, 2024 at 12:00 PM UTC

Progyny, Inc. Earnings Date

Recent Events

May 29, 2024 at 6:00 PM UTC

at Leerink Partners Healthcare Crossroads Conference

May 29, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 23, 2024 at 7:00 PM UTC

Annual Shareholders Meeting

May 22, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 16, 2024 at 12:00 AM UTC

at Bank of America Healthcare Conference

May 10, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 9, 2024 at 8:45 PM UTC

Q1 2024 Earnings Call

May 9, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 12, 2024 at 12:00 AM UTC

ARS: Annual Report to Shareholders

March 19, 2024 at 5:30 PM UTC

at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual)

Related Tickers